Sinovac Biotech Ltd SEC filings SVA
Sinovac Biotech Ltd has 578 filings in SEC EDGAR's recent list, going back to Jan 20, 2000. Its latest annual report, Form 20-F, was filed on Jun 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 17, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 20-F | Notification of late filing | Apr 30, 2026 | Dec 31, 2025 |
| NT 20-F | Filing | Apr 29, 2025 | Dec 31, 2024 |
| SC TO-T/A | Final amendment | Mar 18, 2024 | — |
| 8-A12B/A | Filing | Feb 21, 2024 | — |
| SC TO-T/A | Cover sheet | Feb 2, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2024 | — |
| SC 14D9 | Filing | Jan 18, 2024 | — |
| SC TO-T | Cover sheet | Jan 8, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 10, 2023 | — |
| CORRESP | Letter to the SEC | Oct 5, 2023 | — |
| SC TO-T/A | Filing | Oct 3, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2023 | — |
| SC 14D9 | Filing | Sep 5, 2023 | — |
| CORRESP | Letter to the SEC | Sep 1, 2023 | — |
| SC TO-T | Cover sheet | Aug 25, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2023 | — |
| CORRESP | Letter to the SEC | Jul 10, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2023 | — |
| 8-A12B/A | Filing | Feb 22, 2023 | — |
| 8-A12B/A | Filing | Feb 22, 2022 | — |
| 8-A12B/A | Filing | Feb 22, 2021 | — |
| 8-A12B/A | Filing | Feb 21, 2020 | — |
| 8-A12B | Filing | Feb 22, 2019 | — |
| 8-A12G | Filing | Feb 22, 2019 | — |
| 8-A12B/A | Filing | Jul 3, 2018 | — |
| NT 20-F/A | Filing | May 8, 2018 | Dec 31, 2017 |
| NT 20-F | Filing | Apr 30, 2018 | Dec 31, 2017 |
| 8-A12B/A | Filing | Mar 6, 2018 | — |
| CORRESP | Letter to the SEC | Jan 30, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 22, 2018 | — |
| 8-A12B/A | Filing | Jun 30, 2017 | — |
| NT 20-F | Filing | May 1, 2017 | Dec 31, 2016 |
| 8-A12B/A | Form 8-a12b/a | Mar 24, 2017 | — |
| 8-A12B | Filing | Mar 29, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2010 | — |
| CORRESP | Letter to the SEC | Jul 22, 2010 | — |
| UPLOAD | Letter from the SEC | Jul 13, 2010 | — |
| CORRESP | Letter to the SEC | Jun 15, 2010 | — |
| UPLOAD | Letter from the SEC | May 28, 2010 | — |
| EFFECT | Filing | Nov 30, 2009 | — |
| CERTNAS | Auto-generated paper document | Nov 13, 2009 | — |
| 8-A12B | Filing | Nov 13, 2009 | — |
| 25 | Filing | Nov 13, 2009 | — |
| NT 20-F | Sinovac biotech ltd. 12b-25 extension for 20-f, 12.31.05 | Jun 30, 2006 | Dec 31, 2005 |
| UPLOAD | Letter from the SEC | Jan 20, 2006 | — |
| CORRESP | Letter to the SEC | Jan 12, 2006 | — |
| UPLOAD | Letter from the SEC | Jan 9, 2006 | — |
| CORRESP | Letter to the SEC | Dec 29, 2005 | — |
| UPLOAD | Letter from the SEC | Dec 12, 2005 | — |
| CORRESP | Letter to the SEC | Nov 28, 2005 | — |
| CORRESP | Letter to the SEC | Nov 28, 2005 | — |
| CORRESP | Letter to the SEC | Nov 28, 2005 | — |
| CORRESP | Letter to the SEC | Nov 1, 2005 | — |
| UPLOAD | Letter from the SEC | Oct 12, 2005 | — |
| CORRESP | Letter to the SEC | Sep 21, 2005 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2005 | — |
| CORRESP | Letter to the SEC | Sep 1, 2005 | — |
| CORRESP | Letter to the SEC | Sep 1, 2005 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2005 | — |
| REGDEX | Auto-generated paper document | Feb 15, 2005 | — |
| CERTNYS | Auto-generated paper document | Dec 7, 2004 | — |
| 8-A12B | Sinovac biotech 8-a(12b), 12.06.04 | Dec 7, 2004 | — |
| REGDEX | Auto-generated paper document | Mar 15, 2004 | — |
| 20FR12G/A | Amendment no. 1 | May 22, 2000 | — |
| 20FR12G | Net-force systems, inc. | Jan 20, 2000 | — |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SVA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Antigua and Barbuda
- Headquarters
- Beijing
- SEC filer status
- Accelerated filer
- SEC CIK
- 1084201
- Former names
- NET FORCE SYSTEMS INC (until Jan 13, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.